Join Us at MEDICA | Booth #Hall 1 E26
About MEDICA
MEDICA — Düsseldorf, Germany, International Hospital & Medical Equipment Exhibition is the world’s largest and most influential B2B medical trade fair. The 2026 edition brings together thousands of medical companies from more than 70 countries — decision-makers from healthcare institutions, distributors, and research experts — focusing on IVD, laboratory equipment, smart healthcare, and innovative medical devices. It is a vital stage for Chinese medical technology to reach the world.
- Dates: November 16–19, 2026
- Venue: Messe Düsseldorf, Germany
- Official website: http://medica-de.com
- TargetingOne: Hall 1, E26
TargetingOne x MEDICA 2026
As a leading player in China’s digital PCR field, TargetingOne focuses on independent innovation in molecular diagnostics and has built a complete technology system covering instruments, chips, reagents, and software. Multiple fully automated digital PCR platforms and oncology and infectious disease diagnostic reagents have obtained NMPA Class III Medical Device Registration Certificates. At this year’s MEDICA, we are presenting our flagship products.
Highlights at our booth:
✅ D20 Automatic Digital PCR System — All-in-One ,highly sensitive platform for absolute nucleic acid quantification
✅ Solutions for tumor gene mutation detection
✅ Solutions for pathogenic microorganism nucleic acid detection
✅ Molecular diagnostic solutions for maternal and child health / reproductive health
✅ Discussions on overseas channel partnerships, OEM/ODM, and research collaboration
We look forward to face-to-face, in-depth exchanges with global customers, distributors, and research partners — showcasing the hardcore innovation of China’s molecular diagnostics and exploring overseas market opportunities.
Exploring New Opportunities in Molecular Diagnostics
Düsseldorf, Germany, November 16–19. We cordially invite experts and industry colleagues from around the world to visit TargetingOne(Hall 1, E26). On display will be the D20 Automatic Digital PCR Platform, together with integrated solutions for oncology, pathogens, and maternal and child health — for discussions on clinical applications, academic exchange, distribution partnerships, and localization cooperation.
We are committed to bringing China’s self-developed molecular diagnostics technology to the international stage, empowering diverse molecular testing scenarios with highly sensitive digital PCR, and contributing to the advancement of precision medicine worldwide.